Skip to main content

Health Catalyst, Inc.

HCAT
Exchange
Nasdaq
Industry
Services-Computer Programming, Data Processing, Etc.
SEC CIK
0001636422

In the last 90 days, Health Catalyst, Inc. insiders filed 1 open-market purchase and 0 sales; 127 institutions reported holding it in 13F filings for Q2 2026, worth $104.0M in total; no superinvestor holds it.

13F holders, Q3 2022

Institutional positions in Health Catalyst, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
172
−8 vs. Q2 2022
Shares held
48.8M
−4.04M (−7.6%) vs. Q2 2022
Total value
$473.3M
−$293.3M (−38.3%) vs. Q2 2022
New holders
29
76 more added
Sold out
37
43 more reduced

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting HCAT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 172 institutions
Q1 2021: 190 institutionsQ2 2021: 198 institutionsQ3 2021: 198 institutionsQ4 2021: 186 institutionsQ1 2022: 185 institutionsQ2 2022: 181 institutionsQ3 2022: 172 institutionsQ4 2022: 167 institutionsQ1 2023: 161 institutionsQ2 2023: 154 institutionsQ3 2023: 159 institutionsQ4 2023: 167 institutionsQ1 2024: 174 institutionsQ2 2024: 161 institutionsQ3 2024: 159 institutionsQ4 2024: 168 institutionsQ1 2025: 166 institutionsQ2 2025: 146 institutionsQ3 2025: 145 institutionsQ4 2025: 136 institutionsQ1 2026: 132 institutionsQ2 2026: 127 institutions
Value heldQ3 2022: $473.3M
Q1 2021: $2.05BQ2 2021: $2.68BQ3 2021: $2.67BQ4 2021: $2.19BQ1 2022: $1.39BQ2 2022: $766.6MQ3 2022: $473.3MQ4 2022: $519.1MQ1 2023: $566.5MQ2 2023: $610.2MQ3 2023: $499.7MQ4 2023: $460.5MQ1 2024: $377.4MQ2 2024: $325.7MQ3 2024: $423.2MQ4 2024: $375.6MQ1 2025: $240.9MQ2 2025: $204.2MQ3 2025: $154.3MQ4 2025: $132.0MQ1 2026: $70.9MQ2 2026: $104.0M
Institutions holding HCAT and their total value by quarter
QuarterHoldersValue
Q2 2026127$104.0M
Q1 2026132$70.9M
Q4 2025136$132.0M
Q3 2025145$154.3M
Q2 2025146$204.2M
Q1 2025166$240.9M
Q4 2024168$375.6M
Q3 2024159$423.2M
Q2 2024161$325.7M
Q1 2024174$377.4M
Q4 2023167$460.5M
Q3 2023159$499.7M
Q2 2023154$610.2M
Q1 2023161$566.5M
Q4 2022167$519.1M
Q3 2022172$473.3M
Q2 2022181$766.6M
Q1 2022185$1.39B
Q4 2021186$2.19B
Q3 2021198$2.67B
Q2 2021198$2.68B
Q1 2021190$2.05B

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Health Catalyst, Inc.; share changes are against Q2 2022.

Institutions holding HCAT in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Kozak & Associates, Inc.0$00.00%−405−100.0%Sold out
Private Trust Co NA0$00.00%−306−100.0%Sold out
Sageworth Trust Co of South Dakota0$00.00%−281−100.0%Sold out
EverSource Wealth Advisors, LLC0$00.00%−154−100.0%Sold out
CoreCap Advisors, LLC0$00.00%−120−100.0%Sold out
Capital Advisors, Ltd. LLC0$00.00%−51−100.0%Sold out
Allworth Financial LP0$00.00%−9−100.0%Sold out
Global Retirement Partners, LLC0$00.00%−34−100.0%Sold out
Ronald Blue Trust, Inc.0$00.00%−8−100.0%Sold out
Exane Derivatives––––Not filed